Skip to main content
RCKT
NASDAQ Life Sciences

Rocket Secures $150M Credit Facility from Hercules Capital, Extending Cash Runway

Tom Rudovsky · Reported by BusinessWire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.48
Mkt Cap
$272.241M
52W Low
$2.46
52W High
$5.45
52W Position info
0.8% above low
Off High info
54% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

RCKT is trading near its 52-week low of $2.46 (0.8% above the low).

Summary

Rocket Pharmaceuticals closed a credit facility with Hercules Capital for up to $150 million, receiving $35 million upfront. The staged structure includes $20 million Tranche 1-B and $15 million Tranche 1-C available through 2027, $30 million tied to a Danon disease clinical milestone, and $50 million subject to Hercules' approval. The facility carries a 30-month interest-only period and 48-month maturity, with warrants for 1,755,853 shares at $2.99, 409,699 exercisable after initial draw. Management says the initial draw extends cash runway into Q3 2028, with potential to reach 2029 if further tranches are drawn. This follows the company's recent FDA alignment on the pivotal Phase 2 Danon trial and provides non-dilutive capital to fund the study. Hercules Capital (HTGC) is the lender, but the primary impact is on Rocket's balance sheet and execution risk.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — The 8-K details the facility: $35M Tranche 1-A funded, $20M Tranche 1-B and $15M Tranche 1-C available through 2027, $30M Tranche 2 upon Danon milestone, $50M Tranche 3 subject to approval; warrants for 1,755,853 shares at $2.99, 409,699 exercisable after initial draw.

At the time of this announcement, RCKT was trading at $2.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $272.2M. The 52-week trading range was $2.46 to $5.45. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

RCKT - Latest Insights

RCKT
Oct 06, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.50
Real-time Price: $2.39 info
Change: -$0.111 (-4%) info
Market Cap: $261.812M info
RCKT
Sep 15, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.49
Real-time Price: $2.39 info
Change: -$1.10 (-32%) info
Market Cap: $261.812M info
RCKT
Sep 15, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $3.45
Real-time Price: $2.39 info
Change: -$1.06 (-31%) info
Market Cap: $261.812M info
RCKT
Aug 10, 2026, 4:00 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $3.63
Real-time Price: $2.39 info
Change: -$1.24 (-34%) info
Market Cap: $261.812M info
RCKT
Aug 03, 2026, 7:41 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.14
Real-time Price: $2.39 info
Change: -$0.751 (-24%) info
Market Cap: $261.812M info